|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 738.34 USD | +6.17% |
|
+13.26% | -4.34% |
| 07-30 | Regeneron Pharmaceuticals Shares Rise After Higher Q2 Results | MT |
| 07-30 | Regeneron Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
| Market Cap | 70.75B 61.45B 57.07B 52.63B 99.14B 6,755B 101B 676B 265B 3,355B 266B 260B 11,281B | P/E 2026 * |
19.5x | P/E 2027 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 62.93B 54.66B 50.76B 46.81B 88.18B 6,008B 89.77B 601B 235B 2,984B 236B 231B 10,034B | EV / Sales 2026 * |
3.85x | EV / Sales 2027 * | 3.41x |
| Free-Float |
72.33% | Yield 2026 * |
0.52% | Yield 2027 * | 0.6% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +6.17% | ||
| 1 week | +13.26% | ||
| Current month | +18.41% | ||
| 1 month | +18.41% | ||
| 3 months | +4.42% | ||
| 6 months | -0.42% | ||
| Current year | -4.34% |
| 1 week | 659.53 |  | 740 |
| 1 month | 625.7 | | 740 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Michael Brown
BRD | Director/Board Member | 85 | 1991-05-31 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -200 | 0.0002% | ||
| 2/19/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 2/9/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.17% | +13.26% | +33.13% | -1.04% | 70.75B | |
| -13.51% | -10.70% | +17.04% | +172.20% | 54.35B | |
| +3.25% | +52.70% | +52.70% | +52.70% | 47.19B | |
| -3.42% | +6.77% | -54.41% | -53.97% | 42.48B | |
| -0.62% | +3.64% | +64.19% | -21.60% | 30.91B | |
| -3.23% | +5.40% | +58.59% | +94.94% | 25.76B | |
| +6.29% | +1.58% | +80.16% | -51.19% | 21.62B | |
| -1.08% | -3.06% | -11.02% | +152.02% | 19.91B | |
| -0.13% | +3.10% | +69.03% | +129.42% | 16.9B | |
| -1.68% | -0.95% | +80.05% | +138.64% | 16.33B | |
| Average | -0.79% | +2.90% | +38.95% | +61.21% | 34.62B | |
| Weighted average by Cap. | -0.88% | +3.87% | +31.56% | +50.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.35B 14.2B 13.19B 12.16B 22.91B 1,561B 23.32B 156B 61.12B 775B 61.39B 60.04B 2,606B | 17.66B 15.34B 14.25B 13.14B 24.75B 1,686B 25.2B 169B 66.04B 837B 66.33B 64.87B 2,816B |
| Net income | 4.94B 4.29B 3.98B 3.67B 6.92B 471B 7.04B 47.15B 18.46B 234B 18.54B 18.14B 787B | 5.18B 4.5B 4.18B 3.85B 7.26B 495B 7.39B 49.48B 19.37B 246B 19.46B 19.03B 826B |
| Net Debt | -7.82B -6.79B -6.31B -5.82B -10.96B -747B -11.16B -74.7B -29.25B -371B -29.38B -28.73B -1,247B | -10.51B -9.13B -8.48B -7.82B -14.73B -1,004B -15B -100B -39.31B -498B -39.48B -38.62B -1,676B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$738.34 | +6.17% | 1,460,842 |
| 26-07-29 | US$695.42 | +0.03% | 1,022,421 |
| 26-07-28 | US$695.18 | +4.20% | 900,408 |
| 26-07-27 | US$667.17 | +1.70% | 650,984 |
| 26-07-24 | US$656.01 | +0.63% | 708,392 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
